Announcement • Jan 29
Solarvest BioEnergy Inc., Annual General Meeting, Apr 01, 2025 Solarvest BioEnergy Inc., Annual General Meeting, Apr 01, 2025. Location: british columbia, vancouver Canada Announcement • Nov 29
Solarvest Bioenergy Inc. Appoints Paul Lipoth to the Board Solarvest BioEnergy Inc. announced that Mr. Paul Lipoth a long-term shareholder of the company has joined the board effective immediately. Mr. Lipoth brings years of experience in doing business with TSX Venture companies and will assist with guiding Solarvest through its next phase of development. Announcement • Oct 08
An undisclosed buyer completed the acquisition of Summerville Prince Edward Island manufacturing and R&D facility from Solarvest BioEnergy Inc. (TSXV:SVS.H) An undisclosed buyer agreed to acquire Summerville Prince Edward Island manufacturing and R&D facility from Solarvest BioEnergy Inc. (TSXV:SVS.H) on September 30, 2024.
The expected completion of the transaction is November 2024.
An undisclosed buyer completed the acquisition of Summerville Prince Edward Island manufacturing and R&D facility from Solarvest BioEnergy Inc. (TSXV:SVS.H) on October 8, 2024. Mr. Paul Lipoth a long-term shareholder of the company has joined the board effective immediately. Mr Lipoth brings years of experience in doing business with TSX Venture companies and will assist with guiding Solarvest through its next phase of development. Announcement • Jun 08
Solarvest BioEnergy Inc. Appoints Grant Larsen as Chief Executive Officer Solarvest BioEnergy Inc. at its annual meeting of shareholders held on May 10, 2024, Mr. Grant Larsen has been appointed as the Chief Executive Officer, serving and leading the Company in transition. Mr. Larsen has more than 25 years experience as an officer, CEO, board advisor, corporate executive and entrepreneur. During his career, Mr. Larsen has held positions with senior global companies in pharmaceuticals, OTC, consumer packaged goods and medical devices. His diverse skillset includes extensive advisory roles, strategic consulting, organizational restructuring, keynote speaking and healthcare technology integration. Announcement • Mar 27
Solarvest BioEnergy Inc., Annual General Meeting, May 10, 2024 Solarvest BioEnergy Inc., Annual General Meeting, May 10, 2024. Location: Vancouver, BC Vancouver British Columbia Canada Announcement • Jan 06
Solarvest BioEnergy to Transfer Listing from Tier 2 to NEX, Effective at the Opening on January 9, 2024 In accordance with TSX Venture Policy 2.5, Solarvest BioEnergy Inc. has not maintained the requirements for a TSX Venture Tier 2 company. Therefore, effective at the opening on January 9, 2024, the Company's listing will transfer to NEX, the Company's Tier classification will change from Tier 2 to NEX, and the Filing and Service Office will change from Vancouver to NEX. Further to the TSX Venture bulletin dated September 14, 2023, trading in the shares of the Company will remain suspended. Announcement • Nov 01
Solarvest BioEnergy Inc. Announces Management Changes Solarvest BioEnergy Inc. announced that Mr. Michael Farley has been appointed as President of the Company effective immediately following the resignation of Mr. Claes Ellegaard who has agreed to tender his resignation. Mr. Farley is an entrepreneur and corporate, business advisor to health and wellness companies in international markets. Dr. Farley was involved in dozens of financial, market entry and M&A transactions since the early 2000s. He is also partnered with a corporate advisory firm in Switzerland offering IR services to NA life science small caps in Europe. In the 1990s, Mr. Farley managed technology and investment programs at the Canadian Foreign Affairs Department. He holds a PhD in the Philosophy of Science from the Université de Montréal. Solarvest announced that Mr. Garth Greenham has been appointed as COO of the Company effective October 31, 2023. Mr. Greenham is an executive of the Company and a corporate director with an extensive record with both privately-held and publicly-traded health care companies. He served as President of the global aquaculture division of Novartis Inc. He started his career with Johnson & Johnson (J&J) where he served 15 years mostly with McNeil Pharmaceutical in numerous management positions in Operations and Contract & Export Sales. He joined Cobequid Life Sciences Inc.(KQR) and served as Director of Sales, Marketing & Operations for nine years and helped grow the company to global leader in the field of aquaculture animal vaccines. Announcement • Oct 19
Solarvest BioEnergy Inc. Announces Board Changes Solarvest BioEnergy Inc. announced that Garth Greenham, Michael Farley and Eugenio-Noel Cuesta have been appointed to the board of directors of the Company effective immediately to fill the vacancies left by Claes Ellegaard, who will remain as CEO, Gregory Drohan, and Donal Carroll who have agreed to resign as directors of the Company. Garth Greenham: Mr. Greenham, is the former executive of the Company and a corporate director with an extensive record with both privately-held and publicly-traded health care companies. He served as President of the global aquaculture division of Novartis Inc. He started his career with Johnson &Johnson (J&J) where he served 15 years mostly with McNeil Pharmaceutical in numerous management positions in Operations and Contract &Export Sales. He joined Cobequid Life Sciences Inc. (KQR) and served as Director of Sales, Marketing &Operations for nine years and helped grow the company to global leader in the field of aquaculture animal vaccines. He was COO of Solarvest until April 2023. Eugenio-Noel Cuesta: Mr. Cuesta holds an M. Sc. In Mechanical Engineering, with postgraduate studies in Mechanical Vibration and Nuclear Engineering. He has been responsible for new product testing and implementation for Hydro-Qubec's Testing and Commissioning Group. He also worked as a physicist at their Reactor Physics Group at the Gentilly-2 Nuclear Power Plant from 2006 to 2014. Prior to working at Hydro-Qubec, he was a Professor of Mechanical Engineering at Simon Bolivar University in Caracas, Venezuela. Michael Farley: Mr. Farley is an entrepreneur and corporate, business advisor to health and wellness companies in international markets. Dr. Farley was involved in dozens of financial, market entry and M&A transactions since the early 2000s. He is also partnered with a corporate advisory firm Switzerland offering IR services to NA life science small caps in Europe. In the 1990s Michael managed technology and investment programs at the Canadian Foreign Affairs Department. He holds a PhD in the Philosophy of Science from the Universit de Montral. Announcement • Aug 29
Solarvest BioEnergy Inc., Annual General Meeting, Nov 24, 2023 Solarvest BioEnergy Inc., Annual General Meeting, Nov 24, 2023. Announcement • Feb 03
Solarvest BioEnergy Inc. Appoints Leslie Auld as Chief Financial Officer Solarvest BioEnergy Inc. announced that Leslie Auld has been appointed the company's Chief Financial Officer effective January 30, 2023. Leslie Auld is a seasoned Financial Executive with over 30 years of relevant experience, including a background in Canadian and U.S. publicly listed companies in the pharmaceutical and diagnostic technology industries. She has held executive positions in biotechnology companies including Aeterna Zentaris and most recently as CFO of Tetra Bio-Pharma. Ms. Auld is an experienced financial executive with extensive biotech experience. She is a CPA in Canada and holds a H. BSc., in Pharmacology and Toxicology from Western University and an MBA from the University of Toronto - Rotman School of Management. Announcement • Jan 25
Solarvest Bioenergy Inc. Announces That It Has Been Granted A Patent for Organic Omega-3 in Brazil Solarvest BioEnergy Inc. announced that it has been granted a patent for Organic omega-3 in Brazil. The intellectual property protection concentrates on the production of algal biomass, algal cell cultures, lipid compounds, and compositions thereof, including fatty acids, carotenoids and fat soluble vitamins. This patent adds additional strength to the Company's existing patent portfolio as it commercializes its line of organic Omega-3 products. Brazil is the largest country in South America with population exceeding 217,000,000 the seventh most populous country in the world. The Company is focused on supplying unique "clean label" products to satisfy the demand for premium plant-based, organic Omega-3 health products. In addition, the Company's wholly owned subsidiary Eversea has accelerated efforts to offer organic marketing companies and organic oriented retailers with house branded products based on unique bioavailable Omega-3 ingredient. Channel marketing feedback indicates that there is extensive market demand for the product's unique characteristics, particularly among consumers focused on organic, vegetarian and vegan diets. The Company's patented Omega-3 products have obtained FDA NDI (New Dietary Ingredient) certification, and certified Organic by the USDA and EU. Further to this patent the company has previously been issued organic omega-3 patents in Japan, Australia and India. In addition, the patent is pending in practically every commercially significant global market, including the USA and the EU. Board Change • Nov 16
High number of new and inexperienced directors There are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. 1 highly experienced director. Independent Director Bill Cheliak is the most experienced director on the board, commencing their role in 2009. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Board Change • Nov 04
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. 2 highly experienced directors. President & Director Gerri Greenham is the most experienced director on the board, commencing their role in 2005. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Announcement • Nov 04
Solarvest BioEnergy Inc. Announces Board Changes Solarvest BioEnergy Inc. announced that at the Annual and Special Meeting of shareholders held on October 25, 2022 appointed Claes Ellegaard, current CEO of the Company, as an additional director to increase the total number of directors to four. The Company announced that, in connection with its Collaborative Research and Development Agreement with FSD Pharma Inc., it has appointed Mr. Donal Carroll to the board as a director. Mr. Carroll is an experienced business executive having 20 years of corporate finance leadership and public company experience, as well as deep expertise in syndicate investing both in equity and debt securities. He is currently a director and Chief Financial Officer of FSD Pharma Inc., Solarvests strategic partner. With a balance of prudent financing practices and business insights, Mr. Carroll has successfully guided companies through expansion and growth. Mr. Carroll was previously with Danaher, Alberto Culver (now Unilever and Cardinal Meats, where he was instrumental in major restructuring activities, mergers and acquisitions and the implementations of new internal controls and ERP systems resulting in significant efficiencies through periods of substantial change and strong company growth. Since September 15, 2017, Mr. Carroll has been a Director of Bird River Resources Inc. He holds a CPA-CMA designation as well as a Bachelor of Commerce degree from University College Dublin. The Company announced that, concurrent with the appointment of Mr. Carroll, Gerri Greenham, founder and long-time director and officer, has resigned from the board due to personal reasons. The following are now members of the board of directors of the Company: William Cheliak (Chair), Gregory Drohan, Claes Ellegaard and Donal Carroll. Announcement • Aug 23
Solarvest BioEnergy Inc., Annual General Meeting, Oct 25, 2022 Solarvest BioEnergy Inc., Annual General Meeting, Oct 25, 2022. Announcement • Jul 15
Solarvest Bioenergy Inc. Adds Two People to the Advisory Board Solarvest BioEnergy Inc. announced that has formed added two people to the Advisory Board - Max Goldberg and Jerome Cliché. MAX GOLDBERG: Called "an organic sensation" by The New York Times and named as "one of the nation's leading organic food experts" by Shape magazine, Max Goldberg is the Founder/Editor of Organic Insider, a newsletter read by many of the most influential CEOs in the industry today. He has been covering the organic industry for the past 12 years and also runs the Organic Food Industry group on LinkedIn, which counts nearly 40,000 members from around the world. A former Wall Street banker, Max received his BA from Brown University and his MBA from the Columbia University Graduate School of Business. JEROME CLICHÉ: Is a seasoned corporate advisor of public companies Mr. Cliche has been co-founder of Renmark Financial Communication, a Montreal-based company offering a wide range of integrated Investor Relations and Financial Communications services to small, medium, and large-cap public ccompanies trading on all major North American exchanges. Since 2002, Mr. Cliche has specialized in turnaround situations where he can have a significant influence on management for companies with attractive valuations and little or no published research coverage or exposure in the investment community. Mr. Cliché brings over 30 years of experience in finance, administration, financial planning, business development, and communications as well as leadership in merger and acquisition situations and reorganization. Announcement • Jul 09
Solarvest Bioenergy Inc. Announces that Richard Groome Agrees to Chair its Newly Created Financial Advisory Committee and to Support the Recruitment of Two Additional Members Solarvest BioEnergy Inc. announced that Richard Groome has agreed to chair the company's newly created financial advisory committee and to support the recruitment of two additional members. The Advisory Committee will offer knowledge and skills in relation to fundraising, strategic acquisitions, marketing and to connect Solarvest with potential investors, customers, partners, service providers, employees and media. Richard (Rick) Groome, over the last three decades, was instrumental in creating and building two securities firms, Marleau Lemire and Groome Capital, which funded many successful biotechnology and nutraceutical companies. Among Mr. Groome's achievements are: Launching two securities trading and underwriting houses, with each achieving leading status within 3 years and one traded publicly on the Toronto Stock Exchange. Managing and participating in more than 600 financings representing some $4 billion of small cap deals, with several companies successfully becoming billion and multi-billion-dollar companies. Serving as past Director of the CDNX, the predecessor of the TSX Venture Exchange. Serving on more than 30 boards of directors of emerging growth companies and experience in corporate governance and early start-up situations. Announcement • Mar 19
Solarvest BioEnergy Inc. announced that it expects to receive CAD 2 million in funding Solarvest BioEnergy Inc. (TSXV:SVS) announced a non-brokered private placement of 800,000 unit at a price of CAD 0.25 for gross proceeds of CAD 2,000,000 on March 17, 2021. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to acquire one additional common share of the company at a price of CAD 0.35 per share for a period of one year following closing. In the event that the volume weighted average price of the common shares on the TSX Venture Exchange is equal to or greater than CAD 0.70 per share for a period of 20 consecutive trading days at any time during the period of time commencing 12 months after closing until the expiry of the warrants. The company has paid a cash commission of CAD 1,600 and 8,000 whole share purchase warrants at the same term of the warrants issued in the transaction. Closing may take place in one or more tranches. In addition to accredited investors, the transaction is open to all existing shareholders of the company subject to certain limitations. The aggregate subscription amount to any one subscriber under the existing shareholder exemption cannot exceed CAD 15,000 unless a subscriber has obtained suitability advice. All securities issued pursuant to this financing are subject to a four-month-and-one-day hold period under applicable Canadian securities legislation. The company may pay finders' fees to qualified finders in connection with this financing. Closing is subject to TSX Venture Exchange acceptance. Announcement • Mar 06
Solarvest BioEnergy Inc. Eversea Confirms Launch of the Organic Omega-3 DHA Supplement Across USA SOLARVEST BIOENERGY INC. provided an update to the December 21, 2020 press release of its highly-bioavailable Organic Omega-3 Childrens Supplement. The product, marketed under the Companys Eversea brand, is the Organic Omega-3 childrens fruit drop. Eversea seeks to benefit from the extensive and growing market demand for organic, vegetarian and vegan diets. Everseas organically certified supplement holds a competitive advantage with several differentiating factors focused on sustainability, environmental conservation, bioavailability and purity, establishing a new market segment for Organic Omega-3 nutraceuticals. The Eversea Organic Omega-3 Fruit Drop is now available to health conscientious customers throughout the USA directly from its e-commerce web site. This initial Childrens Omega-3 supplement, being Non-GMO, USDA Organic and EU Organic Certified is a unique and a premium entry product that is positioned to take advantage of the significant and growing demand for plant-based products. Everseas Organic Omega-3 is over 80% dried fruit, contains no added sugar, tests free from all common allergens and contains the Companys patented and highly bioavailable Organic Omega-3 DHA powder. The Company further reports that a second product run with its German-based organically certified manufacturer has now successfully concluded. Beyond the Companys intent to supplement inventory levels, this second Organic DHA ingredient batch will be offered to interested parties both inside and outside North America who have already shown interest in the Organic Omega-3 products. In addition to Company-driven product alternatives, Eversea is engaged to advance the development of a second adolescent offering to complement its Natural Fruit Drop. This product is anticipated to provide organic oriented retailers with house branded products using Everseas Omega-3 DHA active ingredient to provide a patented competitive advantage. The Company is reaching out to larger established distributors to secure a distribution pipeline for its Organic Omega-3 products under the Companys Eversea Brand or other Home Brands to achieve scalability and allow the Company to readily market their Organic Omega-3 products. Is New 90 Day High Low • Jan 12
New 90-day high: CA$0.21 The company is up 133% from its price of CA$0.09 on 09 October 2020. The Canadian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is down 1.0% over the same period. Announcement • Aug 25
Solarvest Bioenergy Inc. Announces its German-Based Contractors Resumes Normal Operations Solarvest BioEnergy Inc. announced that the Company's German-based contractors have resumed normal operations after a slow-down related to the COVID-19 pandemic. The Company is now advancing toward commercial production of its pa- tented Omega-3 products. During the slowdown, the Company was able to improve its proprietary process design as well as certify related equipment and further streamline operational logistics. The Company's patented, chewable, Omega-3 products are organic-certified and algae-based. They are also considered sustainable and suitable for plant-based diets, which contributes to their uniqueness and fills an unmet market need in the essential Omega-3 health products market. Achieving organic certification is a key market differentiator in the growing Omega-3 worldwide market. The Company's commercial production process will utilize a clean-culture system which ensures the absence of envi- ronmental contaminants often found in ocean-based products. The Company will continue to move its proprietary for- mulation and processes to the German production facilities. 
